- Country: USA
- Summary: Drug Discovery for Nervous System Disorders (R01 Clinical Trials not Allowed)
- UST Ref No: 60528862
- Deadline: 07 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-22-031
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
CFDA Number : 93.242 -- Mental Health Research Grants93.273 -- Alcohol Research Programs93.279 -- Drug Abuse and Addiction Research Programs93.866 -- Aging Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Jan 07, 2025
Posted Date : Nov 29, 2021
Description: Reissue of PAR-19-147 This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents. - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDrug Discovery for Nervous System Disorders (R01 Clinical Trials not Allowed) - USA Tender
The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Drug Discovery for Nervous System Disorders (R01 Clinical Trials not Allowed). This tender is published on USARFP under UST Ref No: 60528862 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-07.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
